V. S. Madzorera

Most-cited papers

1. SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals

   S. Richardson, V. S. Madzorera, H. Spencer, N. Manamela +21 more

   2022medRxiv116 citations Open access

   Semantic Scholar

   Save

2. SARS-CoV-2 correlates of protection from infection against variants of concern

   K. Sun, J. Bhiman, S. Tempia, J. Kleynhans +16 more

   2024Nature Medicine32 citations Open access

   Semantic Scholar

   Save

3. Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b–2a trial

   S. Madhi, G. Kwatra, S. Richardson, A. Koen +33 more

   2022Lancet. Infectious Diseases (Print)21 citations Open access

   Semantic Scholar

   Save

4. SARS-CoV-2 correlates of protection from infection against variants of concern

   K. Sun, J. Bhiman, S. Tempia, J. Kleynhans +17 more

   2024medRxiv8 citations Open access

   Semantic Scholar

   Save

5. Population shift in antibody immunity following the emergence of a SARS-CoV-2 variant of concern

   J. Bhiman, V. S. Madzorera, Q. Mkhize, C. Scheepers +16 more

   2025Scientific Reports3 citations Open access

   Semantic Scholar

   Save

6. Durability of ChAdOx1 nCoV-19 (AZD1222) Vaccine and Hybrid Humoral Immunity Against Variants Including Omicron BA.1 and BA.4 Six Months after Vaccination: A Randomised, Phase 1b/2a Trial

   S. Madhi, G. Kwatra, R. Welch, A. Koen +33 more

   2022Social Science Research Network0 citations Open access

   Semantic Scholar

   Save